{"title":"Application of Artificial Intelligence in the Diagnosis and Treatment of COVID-19 Lung Disease","authors":"Jalaeian Zaferani, Teshnehlab, Nadji","doi":"10.31038/jipc.2021122","DOIUrl":null,"url":null,"abstract":"COVID-19 disease spread worldwide in 2019 from Wuhan, China, for unknown reasons [1,2]. The disease was caused by the SARS-CoV-2 virus and infected many people in different parts of the world in a short time. According to global statistics, about 255 million people have been infected with the illness so far, and 5.12 million people have died from it [3]. Emergencies have led health professionals and centers to develop guidelines to prevent the transmission of the sickness chain and to treat people. Common symptoms include fever, cough, tiredness, and loss of smell or taste. In addition, patients may experience sore throat, headache, irritated eyes, and diarrhea. More severe cases of the disease can include chest pain and shortness of breath which the person should go to a doctor and hospital immediately [4]. Since its inception, the virus has shown mutations that have led to increased transmission and severity of the disease, which has ultimately increased mortality. Some obvious variants are Alpha, Beta, Gamma, and Delta species which the Delta mutation has become more intense. Although the process of universal vaccination has made humans more resistant to the virus, the disease is now leading to injury and death [5].","PeriodicalId":258672,"journal":{"name":"Journal of International Perspectives on COVID-19","volume":"37 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2021-11-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of International Perspectives on COVID-19","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.31038/jipc.2021122","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
COVID-19 disease spread worldwide in 2019 from Wuhan, China, for unknown reasons [1,2]. The disease was caused by the SARS-CoV-2 virus and infected many people in different parts of the world in a short time. According to global statistics, about 255 million people have been infected with the illness so far, and 5.12 million people have died from it [3]. Emergencies have led health professionals and centers to develop guidelines to prevent the transmission of the sickness chain and to treat people. Common symptoms include fever, cough, tiredness, and loss of smell or taste. In addition, patients may experience sore throat, headache, irritated eyes, and diarrhea. More severe cases of the disease can include chest pain and shortness of breath which the person should go to a doctor and hospital immediately [4]. Since its inception, the virus has shown mutations that have led to increased transmission and severity of the disease, which has ultimately increased mortality. Some obvious variants are Alpha, Beta, Gamma, and Delta species which the Delta mutation has become more intense. Although the process of universal vaccination has made humans more resistant to the virus, the disease is now leading to injury and death [5].